BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) saw a significant growth in short interest during the month of August. As of August 14th, there was short interest totaling 13,334 shares, a growth of 172.9% from the July 30th total of 4,886 shares. Based on an average daily trading volume, of 5,549 shares, the short-interest ratio is presently 2.4 days.
BioSyent Price Performance
BIOYF traded down $0.01 during midday trading on Friday, hitting $11.43. 131 shares of the company traded hands, compared to its average volume of 2,632. BioSyent has a 52 week low of $7.63 and a 52 week high of $12.00. The company’s 50-day moving average is $10.54 and its 200 day moving average is $10.62.
About BioSyent
BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.
BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.
Recommended Stories
- Five stocks we like better than BioSyent
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
- Amazon’s Zoox Push Tests Tesla’s Robotaxi Premium as Waymo Widens Its Lead
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.
